Sep 18, 2026•3 min read
FDA Grants Approval for AdaRe Pharm’s Potassium Chloride Extended‑Release Tablets (ANDA 076368)
The FDA approved ANDA 076368 for two extended‑release potassium chloride tablets (10 mEq and 20 mEq) marketed by AdaRe Pharm and manufactured by Sun Pharmaceutical.